Advisor Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $232K | Buy |
715
+8
| +1% | +$2.6K | ﹤0.01% | 2277 |
|
2019
Q3 | $193K | Sell |
707
-80
| -10% | -$21.8K | ﹤0.01% | 2350 |
|
2019
Q2 | $420K | Buy |
787
+246
| +45% | +$131K | ﹤0.01% | 1741 |
|
2019
Q1 | $274K | Buy |
541
+98
| +22% | +$49.6K | ﹤0.01% | 2023 |
|
2018
Q4 | $218K | Buy |
443
+78
| +21% | +$38.4K | ﹤0.01% | 2026 |
|
2018
Q3 | $334K | Buy |
365
+263
| +258% | +$241K | ﹤0.01% | 1782 |
|
2018
Q2 | $75K | Buy |
102
+12
| +13% | +$8.82K | ﹤0.01% | 2766 |
|
2018
Q1 | $144K | Sell |
90
-19
| -17% | -$30.4K | ﹤0.01% | 2248 |
|
2017
Q4 | $97K | Buy |
109
+5
| +5% | +$4.45K | ﹤0.01% | 2602 |
|
2017
Q3 | $38K | Buy |
104
+1
| +1% | +$365 | ﹤0.01% | 3135 |
|
2017
Q2 | $31K | Buy |
103
+16
| +18% | +$4.82K | ﹤0.01% | 3172 |
|
2017
Q1 | $31K | Buy |
87
+8
| +10% | +$2.85K | ﹤0.01% | 3056 |
|
2016
Q4 | $14K | Sell |
79
-24
| -23% | -$4.25K | ﹤0.01% | 3451 |
|
2016
Q3 | $27K | Buy |
103
+7
| +7% | +$1.84K | ﹤0.01% | 2963 |
|
2016
Q2 | $19K | Buy |
+96
| New | +$19K | ﹤0.01% | 3095 |
|